Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Sitagliptin Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on Metformin Alone In a 24-week placebo-controlled trial of sitagliptin 100 mg administered once daily added to a twice daily metformin regimen, there were no adverse reactions reported regardless of investigator assessment of causality in 5% of patients and more commonly than in patients given placebo
Call 843-347-3900 or schedule online
Consultations are $75 and include a comprehensive health assessment.
Clinical trials expanding The success of GLP-1 agonists has validated peptides as a therapeutic class
Fontes-Dutra M, Santos-Terra J, Deckmann I, Brum Schwingel G, Della-Flora Nunes G, Hirsch MM, Bauer-Negrini G, Riesgo RS, Bambini-Jnior V, Hedin-Pereira C, Gottfried C
doi.org/10.1002/ibd.20453 Seiwerth, S., et al
US$ 24.94
US$ 24.67
US$ 26.07
US$ 20.79
US$ 24.25
US$ 26.76
US$ 24.59
US$ 22.52
US$ 21.08
US$ 26.88
US$ 22.09
